These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21687942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y, Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, Qin WX, Tang ZY, Fan J, Zhou J.
    Cancer; 2013 Mar 01; 119(5):993-1003. PubMed ID: 23132676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
    Hum Pathol; 2010 Nov 01; 41(11):1558-65. PubMed ID: 20621328
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.
    J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
    Miwa S, Miyagawa S, Soeda J, Kawasaki S.
    Cancer; 2002 Jan 15; 94(2):428-34. PubMed ID: 11900228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J.
    Clin Cancer Res; 2009 Sep 01; 15(17):5518-27. PubMed ID: 19706825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Strong expression of CD133 is associated with increased cholangiocarcinoma progression.
    Leelawat K, Thongtawee T, Narong S, Subwongcharoen S, Treepongkaruna SA.
    World J Gastroenterol; 2011 Mar 07; 17(9):1192-8. PubMed ID: 21448425
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F, Li D, Chen J, Liu W, Cai L, Li J, Jiang P, Liu Z, Zhao X, Guo F, Li X, Wang S.
    Eur J Cancer; 2013 May 07; 49(7):1771-80. PubMed ID: 23313142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Aishima S, Taguchi K, Terashi T, Matsuura S, Shimada M, Tsuneyoshi M.
    Mod Pathol; 2003 Oct 07; 16(10):1019-27. PubMed ID: 14559985
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP, Zhang JX, Gu SP, Wu YB, Liu JF.
    Neoplasma; 2012 Oct 07; 59(4):409-15. PubMed ID: 22489696
    [Abstract] [Full Text] [Related]

  • 19. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2009 Feb 07; 40(2):174-80. PubMed ID: 18835624
    [Abstract] [Full Text] [Related]

  • 20. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
    Uenishi T, Yamazaki O, Tanaka H, Takemura S, Yamamoto T, Tanaka S, Nishiguchi S, Kubo S.
    Ann Surg Oncol; 2008 Feb 07; 15(2):583-9. PubMed ID: 17955299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.